
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Take a look through key stories from last month, including regulatory news, trial updates, and other practice-changing advancements.
There was a wealth of important developments across urology in July 2025, with notable advancements in benign conditions such as stress urinary incontinence (SUI) and benign prostatic hyperplasia (BPH).






